SAB BIO Highlights Data in Multiple Presentations at EASD

As SAB initiates its Phase 2b SAFEGUARD study for SAB-142 in new-onset Stage 3 autoimmune T1D patients, EASD provided an opportunity to connect ...
Northwestern University Clinical and Translational Sciences Institute

Collaborative Approach to Defining Data Sharing Metrics Named Finalist in NIH S-index Challenge

A collaborative multidisciplinary team that includes Northwestern’s Kristi Holmes, PhD has been named an NIH S-index ...

Revelation Biosciences Announces Special Webcast to Review Positive Top-line Clinical Data

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...
pharmaphorum

Scancell points to 'strong' melanoma vaccine data

UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...
TipRanks on MSN

SAB Biotherapeutics highlights data in multiple presentations at EASD

SAB Biotherapeutics (SABS) highlighted multiple presentations made at the 61st Annual Meeting of the European Association for the Study of ...
Barron's

Bio-Rad Laboratories Inc. Cl A

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the ...